Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphosys Ag ADR (NQ: MOR )

5.035 -0.025 (-0.49%)
Streaming Delayed Price Updated: 11:29 AM EST, Feb 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,948
Open 5.070
Bid (Size) 5.020 (13)
Ask (Size) 5.060 (6)
Prev. Close 5.060
Today's Range 4.990 - 5.080
52wk Range 3.170 - 7.985
Shares Outstanding 32,890,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
Via ACCESSWIRE

Performance

YTD
+41.63%
+41.63%
1 Month
+26.19%
+26.19%
3 Month
+1.92%
+1.92%
6 Month
-14.08%
-14.08%
1 Year
-35.20%
-35.20%

More News

Read More
MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
MorphoSys AG: Financial Calendar 2023
Via ACCESSWIRE
MorphoSys Earnings Preview
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
MorphoSys Inks Licensing Agreement With Novartis For Preclinical Cancer Programs
Via Benzinga
Is The Oil And Gas Bull Market Over? This 2X Leveraged ETF Inversely Tracks Exxon, Occidental And More
Via Benzinga
MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results
From MorphoSys AG
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Scheduled For November 16, 2022
Via Benzinga
Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
Via Investor's Business Daily
Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.